Skip to content

Total Versus Subtotal Thyroidectomy in Graves' Disease At AUH

Total Versus Subtotal Thyroidectomy in Graves' Disease : A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04577664
Enrollment
60
Registered
2020-10-08
Start date
2020-11-30
Completion date
2021-12-31
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Goiter

Brief summary

The main aim of work is to compare between subtotal and total thyroidectomy intra and postoperatively to identify which technique is better for patient of graves disease

Detailed description

Graves' disease is an autoimmune disease that affects the thyroid gland\[1\] and it's the most common cause of hyperthyroidism. \[2\] Treatment of Graves' disease includes antithyroid drugs ; radioiodine ; and thyroidectomy . patients with Graves' hyperthyroidism can be treated with any of these treatment options. There is a wide geographic variation in the choice of therapy.\[3\] Medical treatment with antithyroid drugs is often accepted as first-choice modality in Europe, followed by radioiodine in case of recurrence. Although surgery offers the advantage of quick control and low morbidity in experienced hands, it is infrequently recommended as initial treatment. Therapy with radioiodine is the most common treatment in the United States, while antithyroid drugs and/or thyroidectomy are used more often in Europe, Japan, and most of the rest of the world.recent literature shows that the relapse rate was the highest among patients who received antithyroid drugs (40%) as compared to those who received radioiodine (21%) or Surgery (5). \[4\] Two different surgical techniques are used for the treatment of Graves' hyperthyroidism: a total thyroidectomy (TT) in which the entire gland is removed and a subtotal thyroidectomy (STT) , in which most of the gland is removed leaving a small unilateral or bilateral remnant in situ about 4-5 grams. Although thyroidectomy has been broadly considered as a viable alternative theapy for patients with Graves' disease , the resection extent and remnant size of thyroid gland remains controversial.\[6\] Although total thyroidectomy has a lower recurrence rate it has raised a concern that a more radical operation would increase the complications.\[7\] we intend to perform this analysis based on the published literatures of randomized controlled trials to evaluate the specific risks of thyroid surgery including recurrent hyperthyroididm , post-operative bleeding , recurrent laryngeal nerve injury , hypoparathyroidism and opthalmopathy progression.

Interventions

PROCEDUREtotal thyroidectomy

a total thyroidectomy (TT) in which the entire gland is removed

PROCEDUREsubtotal thyroidectomy

subtotal thyroidectomy (STT) , in which most of the gland is removed leaving a small unilateral or bilateral remnant in situ about 4-5 grams.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* patients diagnosed clinically, biochemically and immunologically with Graves' disease who will undergo thyroidectomy at general surgery department in AUH.

Exclusion criteria

* 1- previous thyroid or parathyroid surgery. * 2- recurrent hyperthyroidism after radioiodine therapy. * 3- preoperative recurrent laryngeal nerve palsy. * 4- patients unfit for operation. * 5- inability to comply with the follow-up protocol. * 6- suspicious thyroid nodules.

Design outcomes

Primary

MeasureTime frameDescription
comparison between total thyroidectomy vs subtotal thyroidectomy in graves' diseasebaselinePrevlance of recurrent hyperthyroidism

Secondary

MeasureTime frameDescription
comparison between total thyroidectomy vs subtotal thyroidectomy in graves' diseasebaselinePostoperative hypocalcemia and hypoparathyroidism.

Contacts

Primary Contactahmed nasr ahmed, resident doctor
zorakovic11@gmail.com+201064594779
Backup Contacthesham ali reyad, professor of general surgery
heshamreyad@aun.edu.eg+201005015757

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026